Your browser doesn't support javascript.
loading
Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial.
Wendtner, Clemens M; Hallek, Michael; Fraser, Graeme A M; Michallet, Anne-Sophie; Hillmen, Peter; Dürig, Jan; Kalaycio, Matt; Gribben, John G; Stilgenbauer, Stephan; Buhler, Andreas; Kipps, Thomas J; Purse, Brendan; Zhang, Jennie; De Bedout, Sabine; Mei, Jay; Chanan-Khan, Asher.
Afiliación
  • Wendtner CM; a Klinikum Schwabing, Academic Teaching Hospital of University of Munich , Munich , Germany ;
  • Hallek M; b Department I of Internal Medicine , University of Cologne , Cologne , Germany ;
  • Fraser GA; b Department I of Internal Medicine , University of Cologne , Cologne , Germany ;
  • Michallet AS; c Cologne Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases (CECAD) , Cologne , Germany ;
  • Hillmen P; d Juravinski Cancer Centre, McMaster University , Hamilton , Ontario , Canada ;
  • Dürig J; e Hospices Civils De Lyon, Centre Hospitalier Lyon Sud , Pierre Bénite , Lyon , France ;
  • Kalaycio M; f St James's Institute of Oncology , Leeds , UK ;
  • Gribben JG; g University Hospital Essen , Essen , Germany ;
  • Stilgenbauer S; h Cleveland Clinic , Cleveland , OH , USA ;
  • Buhler A; i Barts Cancer Institute, Queen Mary, University of London , London , UK ;
  • Kipps TJ; j Department of Internal Medicine III , Ulm University , Ulm , Germany ;
  • Purse B; j Department of Internal Medicine III , Ulm University , Ulm , Germany ;
  • Zhang J; k University of California San Diego Moores Cancer Center , La Jolla , CA , USA ;
  • De Bedout S; l Celgene Corporation , Summit , NJ , USA ;
  • Mei J; l Celgene Corporation , Summit , NJ , USA ;
  • Chanan-Khan A; m Celgene Corporation , Boudry , Switzerland ;
Leuk Lymphoma ; 57(6): 1291-9, 2016.
Article en En | MEDLINE | ID: mdl-26763349
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Talidomida / Leucemia Linfocítica Crónica de Células B / Factores Inmunológicos / Antineoplásicos Tipo de estudio: Clinical_trials Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Talidomida / Leucemia Linfocítica Crónica de Células B / Factores Inmunológicos / Antineoplásicos Tipo de estudio: Clinical_trials Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article